D86.3
Sarcoidosis of skin
Clinical Classification Guidelines
Medical Intelligence & Overview
Sarcoidosis of the skin, classified under ICD-10 code D86.3, is a condition characterized by the development of granulomas—tiny clusters of inflammatory cells—within the skin tissues. This form of sarcoidosis arises when the immune system reacts abnormally, creating persistent inflammatory nodules on the skin's surface. Though it can appear anywhere on the skin, common sites include the face, arms, legs, and trunk. The condition may occur independently or as part of systemic sarcoidosis that affects multiple organs. Recognizing and understanding this skin manifestation is essential for appropriate medical management and monitoring.
Causes & Symptoms
Clinical Causes: Immune system malfunction leading to granuloma formation Genetic predisposition in some individuals Environmental exposures such as silica dust or certain chemicals Infections triggering abnormal immune responses Possibility of sarcoidosis occurring without a clear external trigger
Key Symptoms: Pink, red, or purple skin nodules or bumps Lesions that are often firm and may be raised Localized or widespread skin involvement Occasionally, skin lesions may ulcerate or become inflamed Discoloration or hyperpigmentation in affected areas Possible itching or tenderness around skin lesions
Diagnostic & Treatment
Diagnosis Path: Diagnosis of sarcoidosis of the skin typically involves a combination of clinical examination, skin biopsy, and ruling out other skin conditions. A biopsy of a skin lesion reveals non-caseating granulomas—granules of immune cells without necrosis. Additional tests such as chest X-rays or scans may be performed to determine if other organs are involved. Blood tests evaluating inflammation markers and calcium levels can support the diagnosis. A thorough medical history and physical examination help differentiate sarcoidosis from other dermatologic or systemic conditions.
Treatment Protocols: Management of skin sarcoidosis often involves medications aimed at reducing inflammation and controlling immune activity. Common treatments include corticosteroids applied topically or administered systemically for more extensive disease. Other options may involve immunosuppressive drugs like methotrexate, hydroxychloroquine, or azathioprine in resistant cases. Light therapy, such as ultraviolet B (UVB), can be beneficial for certain skin lesions. Regular follow-up is essential to monitor for treatment response and the potential progression of systemic involvement. Supportive skin care and monitoring for any changes in skin appearance are also important components of ongoing management.
Clinical Advice & FAQs
Billing Guidance
Is D86.3 a billable ICD-10 code?
Yes, D86.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D86.3?
Clinical documentation must specify the nature of Sarcoidosis of skin and any associated comorbidities for accurate reporting.
Cite this Clinical Reference